However, the release of soluble tau species in physiological conditions allows important signalling roles of extracellular tau (Gomez-Ramos et al., 2008; Pooler et al., 2013) and this tau function may be lost in Alzheimer’s disease (Croft et al., 2017). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.